Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
A larger and methodologically careful Scandinavian cohort study by Pasternak and colleagues, published in the BMJ in 2024, pointed the other way
The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal
About the Author Steven Chen, MD, MPH, Contributor Disclaimer: As a service to our readers, Harvard Health Publishing provides access to our library of archived content
These medications not only help in weight loss but also improve various metabolic parameters
Those with severe obesity (BMI 35 kg/m), a group where significant body weight reductions have been observed in research settings
Novo Nordisk responds, noting study limitations Novo Nordisk, the maker of these drugs, noted limitations in the study design
